scholarly journals Pathomorphological changes of flunixin meglumine toxicity in layer chicks

2016 ◽  
Vol 8 (3) ◽  
pp. 1253-1259 ◽  
Author(s):  
R. A. Patel ◽  
K. B. Kapadiya ◽  
D. J. Ghodasara
Keyword(s):  
Body Weight ◽  
Clinical Signs ◽  
Weight Ratio ◽  
Group Iv ◽  
Mean Values ◽  
Group Iii ◽  
Treatment Groups ◽  
Flunixin Meglumine ◽  
Group I ◽  
Urate Crystals

The aim of the 21 day toxicity study was to evaluate the pathomorphological effect of flunixin meglumine in layer chicks. The chicks of Group I were kept as control while groups II, III and IV were fed with diet containing flunixin meglumine @ 10 ppm, 25 ppm and 50 ppm respectively for 21 days. Clinical signs viz. anorexia, dullness,lethargy, lameness and uneven growth were noticed in chicks of treatment groups III and IV only. Maximum mortality was observed in group IV (12%) followed by group III (4%). A dose dependant reduction in body weight was observed in all the treatment groups. The mean values of Kidney: Body weight ratio was significantly increased in group IV. The plasma uric acid, creatinine and BUN values were significantly increased in group III whereas increase in group IV was highly significant. Grossly, there was deposition of chalky white urates on serosal surface of kidney, heart and liver in chicks of group IV which died during experiment. Microscopically, lesions were characterized by varying degrees of congestion, haemorrhages, degeneration, necrosis and deposition of urate crystals in visceral organs of group III and group IV chicks. The intensity and distribution of pathological lesions were more severe in chicks of group IV, followed by chicks of group III. The overall lesions gave an impression that flunixin meglumine was nephrotoxic in nature.

scholarly journals The Efficacy Study of Duramectin, Oxfendazole, Piperazine, and Pyrantel pamoate Against Gastrointestinal Worms In Horses In Yogyakarta Special Region*)

2019 ◽  
Vol 37 (1) ◽  
pp. 112
Author(s):  
Yuriadi Yuriadi ◽  
Ida Tjahajati ◽  
Soedarmanto Indarjulianto ◽  
Irkham Widiyono
Keyword(s):  
Body Weight ◽  
Clinical Symptoms ◽  
Research Result ◽  
Group Iv ◽  
Weight Group ◽  
Group Iii ◽  
Treatment Groups ◽  
Central Java ◽  
Group I ◽  
Special Region

ABSTRACT This research aimed at determining the efficacy of duramectin, oxfendazole, piperazine, and pyrantelpamoate against gastrointestinal worms in horses in Yogyakarta Special Region and Central Java. The object of research involved 40 horses diagnosed with gastrointestinal worm infection. Prior to the research, all of the horses were subjected to examination for clinical symptoms and parasitology laboratory checkup for signs of worm eggs in their feces, and they were pronounced positive for experiment animals with at least 150 eggs per gram of feces per horse. The research horses were weighed to determine the dose of worm medication to be used. The research horses are divided into four treatment groups, each group consists of ten horses. Group I was given duramectin with a dose of 0.2 mg/kg of body weight. Group II was given oxfendazole with a dose of 7.5 mg/kg of body weight, Group III was given 125 mg Piperazin treatment per kilogram of body weight and Group IV was given pyrantelpamoate with a dose of 20 mg/kg of body weight. After receiving themedication, the horses were observed to document the progress in terms of clinical symptoms and the amount and type of worm eggs in their feces every three days for four times in a row. The research data results were tabulated and were descriptive-comparatively analyzed.The research result showed varying efficacy level of worm medication for horses. Oxfendazole kills Strongylus and Parascaris worms. Duramectin kills Strongylus worms and reduce some of the Parascaris worms. Piperazineandpyrantelpamoate kills the Strongylus wormsand reduce some of the Parascaris. Keywords: horses, gastrointestinal worms, Duramectin, Oxfendazole, Piperazine, PyrantelPamoate.  

http://arccjournals.com/journal/indian-journal-of-animal-research/B-3423

2017 ◽  
Author(s):  
Meenakshi Bhagat ◽  
Shilpa Sood ◽  
Anish Yadav ◽  
Rajesh Katoch ◽  
Dibyendu Chakraborty ◽  
...  
Keyword(s):  
Body Weight ◽  
Clinical Signs ◽  
Group Iv ◽  
Clinical Disease ◽  
Group Iii ◽  
Group I ◽  
Healthy Control ◽  
Progressive Weakness ◽  
Average Body ◽  
Overall Mortality

The present study was conducted to determine the clinco-haematological effects of a well characterized Cryptosporidium parvum isolate in Swiss albino mice. Sixty female mice were divided into four groups. Group I mice served as healthy control. In group II, C. parvum oocysts were administered orally, mice of group III were given dexamethasone in drinking water whereas group IV mice were given dexamethasone along with C. parvum oocysts. Clinical signs were more severe in immunosuppressed infected mice and observed dullness, depression, inappetance, poor fur condition, progressive weakness, and decrease in body weight. In addition, mice in group IV showed profuse diarrhoea. An overall mortality rate of 7% and 20% was seen in group III and IV animals, respectively. Animals of group IV had significantly lower average body weight as compared to other groups around the time of peak infection with C. parvum which was recorded to be around 10th DPI. Based on severity of clinical disease and oocyst shedding intensity significant leukocytosis along with neutrophilia and lymphocytopenia was observed in group IV mice at 10th DPI as compared to mice in other groups. It was concluded that experimental infection with C. parvum in mice caused a severe clinical disease which peaked around 10th day and was seen to subsequently resolve around 15 DPI.

TESTOSTERONE DECREASE AND OESTROGEN INCREASE IN MALE PATIENTS WITH OBESITY

1979 ◽  
Vol 91 (3) ◽  
pp. 553-563 ◽  
Author(s):  
H. K. Kley ◽  
H. G. Solbach ◽  
J. C. McKinnan ◽  
H. L. Krüskemper
Keyword(s):  
Body Weight ◽  
Sex Hormones ◽  
Plasma Concentrations ◽  
Clinical Signs ◽  
Free Testosterone ◽  
Control Group ◽  
Obese Patients ◽  
Group Iii ◽  
Group I ◽  
Male Patients

ABSTRACT The concentration of sex hormones and their binding in the plasma were measured in male patients (20–40 years old), who weighed 140–170 % (I), 170–200 % (II) and > 200 % (III) of their ideal weight. Correlated to body weight, there is a reduction in the total concentration of testosterone, which, in the very obese patients, amounts to 41 % (in group I: 85 % in group II: 68 % P < 0.001) of that found in an age-matched healthy control group of subjects of "normal" body weight (90–115 % of the ideal body weight; n: 20). Androstenedione values show only a trend downwards (from 0.94 to 0.72 ng/ml plasma), while the oestrogen values increase significantly; oestrone increases by a factor of 1.09 (I), 1.43 (II; P < 0.001) and 1.69 (III; P < 0.001) and oestradiol by 1.13, 1.43 P < 0.001) and 1.76 (P < 0.001), respectively. Despite the fall in testosterone there are no clinical signs of hypogonadism, as SHBG (from 5.1 ± 0.8 in the controls to 2.4 ± 0.6 ×10−8 Mol/l in the very obese patients of group III) and the protein-bound fraction of testosterone also decrease. As a result the concentration of free testosterone remains constant (120 pg/ml), except in the very obese (93 pg/ml). Because of the different affinity of the binding proteins for testosterone and oestradiol the ratio of free oestradiol: free testosterone shifts less strongly in favour of the feminizing hormone (11.1 × 10−3 in group III as compared to 4.1 × 10−3 in the controls), than is suggested by the total hormone concentrations. A disturbance in the gonadal function of the pituitary gland or the testes is not present, since the concentration of LH is normal and the testicular response to HCG in very obese patients adequate (increase of testosterone by a factor of 3.11 as compared to 2.23 in the controls). The cause of the decrease in testosterone and SHBG is unknown, while the increase of plasma oestrogens is likely to be due to the increased conversion of androgens to oestrogens in the adipose tissue, which clearly plays an important role for plasma concentrations of sex hormones in obese patients.

scholarly journals Comparative effects of Alpha Tocopherol and Ascorbic Acid on Chronic Stress Induced Neuropeptide Y Derangements

2020 ◽  
Vol 9 (1) ◽  
pp. 33-39
Author(s):  
Saadia Zainab ◽  
Tahir Ahmad Munir ◽  
Anjum Ilahi ◽  
Adnan Saleem Khan
Keyword(s):  
Ascorbic Acid ◽  
Body Weight ◽  
Neuropeptide Y ◽  
Chronic Stress ◽  
Restraint Stress ◽  
Group Iv ◽  
Alpha Tocopherol ◽  
Chronic Restraint Stress ◽  
Group Iii ◽  
Group I

Background: Chronic stress decreases resilience of the body mainly due to hormonal imbalance. Neuropeptide Y-ergic system is abnormally regulated in chronic stress due to reduction-oxidation imbalance. The antioxidants such as alpha-tocopherol and ascorbic acid reduce this imbalance with positive effect on neuropeptide Y synthesis and release. This study was aimed to compare the protective effects of alpha-tocopherol and ascorbic acid on plasma neuropeptide Y levels in chronic stress.Material and Methods: This quasi-experimental study was done at Al-Nafees Medical College in collaboration with National Institute of Health Islamabad from January 2015 to January 2016 after taking institutional approval. Sixty male Sprague Dawley rats were obtained and divided equally into four groups; group I (control), group II (restraint stress group - chronic restraint stress six hours daily for 28 days), group III (restraint stress + alpha-tocopherol 50mg/kg body weight /day), and group IV (restraint stress + ascorbic acid 100mg /kg body weight /day). Cardiac puncture was done to obtain blood for biochemical analysis.Results: A significant decrease in plasma neuropeptide Y levels was seen in group II compared to group I, group III and group IV. However, alpha-tocopherol administration in group III showed positive effects on maintenance of plasma neuropeptide Y concentration with better p trend than that of ascorbic acid supplementation in group IV.Conclusions: Alpha-tocopherol supplementation has more potent effect than that of ascorbic acid on chronic restraint stress induced derangements in neuropeptide Y levels. It leads to less imbalance in neuropeptide Y levels during chronic stress.Key words: Ascorbic Acid, Alpha-Tocopherol, Chronic Stress, Neuropeptide Y

scholarly journals AMELIORATIVE EFFECTS OF MELATONIN AGAINST 2,4-DICHLOROPHENOXYACETIC ACID TOXICITY IN KIDNEY OF MICE – A HISTOLOGICAL STUDY.

2018 ◽  
Vol 11 (1) ◽  
pp. 78 ◽  
Author(s):  
Ashlesh M Upadhyaya ◽  
Mandava V Rao ◽  
Devendrasinh D Jhala
Keyword(s):  
Body Weight ◽  
Histological Study ◽  
Group Iv ◽  
The Body ◽  
Control Group ◽  
Dichlorophenoxyacetic Acid ◽  
Group Iii ◽  
Group I ◽  
2,4 Dichlorophenoxyacetic Acid ◽  
Acid Toxicity

 Objective: The compound, 2,4-dichlorophenoxyacetic acid (2,4-D), is a systemic phenoxy herbicide and a plant growth regulator. Histopathological effects of 2,4-D alone and in combination with melatonin on the kidney in adult albino male mice of the Swiss strain were evaluated in the present study.Methods: Twenty adult male albino mice weighing between 30 and 40 g were assigned into four groups with five mice in each group. Group I served as control; Group II - melatonin alone (10 mg/kg body weight); Group III - 2,4-D alone (50 mg/kg body weight); and Group IV - 2,4-D + melatonin was given orally for 45 days.Results: It revealed a significant reduction in the body and kidney weights (p<0.001 and p<0.01 respectively) of mice treated with 2,4-D, while the body and kidney weights after treatment of melatonin and 2,4-D + melatonin were comparable to control. Histological study revealed that 2,4-D induced nephrotoxicity evidenced by various histological changes including shrinkage of the glomerulus, tubular dilation, hypertrophy of tubular epithelium, and degeneration of renal tubules.Conclusion: Treating animals with the melatonin along with 2,4-D showed mitigative effects of melatonin and minimized the structural alteration in the kidney of mice appeared due to 2,4-D toxicity. 

scholarly journals Smoking influences on the thickness of marginal gingival epithelium

2003 ◽  
Vol 17 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Cristina Cunha Villar ◽  
Antonio Fernando Martorelli de Lima
Keyword(s):  
Statistical Significance ◽  
Clinical Signs ◽  
Group Iv ◽  
Oral Epithelium ◽  
Group Iii ◽  
Epithelial Thickness ◽  
Gingival Health ◽  
Group I ◽  
Gingival Epithelium ◽  
Health Situation

Smoking patients show reduction of inflammatory clinical signs that might be associated with local vasoconstriction and an increased gingival epithelial thickness. The purpose of this work was to evaluate the thickness of the marginal gingival oral epithelium in smokers and non-smokers, with clinically healthy gingivae or with gingivitis. Twenty biopsies were obtained from four different groups. Group I: non-smokers with clinically healthy gingivae (n = 5). Group II: non-smokers with gingivitis (n = 5). Group III: smokers with clinically healthy gingivae (n = 5). Group IV: smokers with gingivitis (n = 5). These biopsies were histologically processed, serially sectioned at 5 mm, stained with H. E., and examined by image analysis software (KS400), which was used to perform the morphometric evaluation and the quantification of the major epithelial thickness, the epithelial base thickness and the external and internal epithelial perimeters. Differences between the four groups were analyzed using ANOVA test and Tukey's test. The criteria for statistical significance were accepted at the probability level p < 0.05. A greater epithelial thickness was observed in smokers independent of the gingival health situation.

scholarly journals The Influence On Bodyweight In Male Mice (Mus Musculus) Induced By Monosodium Glutamate (Msg)

2018 ◽  
Vol 1 (1) ◽  
pp. 01-03
Author(s):  
Yunita Sari Pane
Keyword(s):  
Body Weight ◽  
Monosodium Glutamate ◽  
Group Iv ◽  
Post Treatment ◽  
The Body ◽  
Male Mice ◽  
Group Iii ◽  
Group I ◽  
Significant Difference ◽  
Group Ii

The used of monosodium glutamate (MSG) oftenly found in almost every food that we consumed everyday. It suggested that MSG can increase appetite, can caused intake much foods, and increased the bodyweight. The aim of study is to prove the changes that occur in male mice by induce of MSG. The experimental study used 24 male mice, 30-45 gram, 12-14 weeks divided into 4 groups, ie group-I (negative control/placebo given aquadest 0.2 cc/20gBW mice); group-II, MSG with the dose of 5 mg/gBW mice); group-III, MSG with the dose of 10 mg/gBW mice and group-IV, MSG with the dose of 20 mg/gBW mice. All of these treatments were administered orally for 14 days. Permanent cervical fracture execution was performed at the end of the study. The body weight measured in pre and post treatment. The significant difference of data between different groups was compared by ANOVA followed by Tukey test. The compared of between pre –post treatment used paired test to analyze the changes of bodyweight This study proved that the comparison of mean values ± SEM of body weight between groups were not significantly different; group I (39,83±3,26), group II (39,33±2,04), group III (38,00±1,39) and group IV (38,33±1,76) (p = 0.930) and the changes of bodyweight pre and post treatmen also not significantly different, whereas p > 0.05. The study concluded that no changes in the body weight between groups and pasca induced by MSG. In the future studies, we consider to examining the effects MSG with longer of duration and more variations doses in MSG.

scholarly journals P749 Echocardiographic risk factors of functional ischemic mitral regurgitation in patients with first acute myocardial infarction

2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
J Kochanowski ◽  
R Piatkowski ◽  
P Scislo ◽  
M Budnik ◽  
M Marchel ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Mitral Regurgitation ◽  
Left Ventricular ◽  
Group Iv ◽  
Ischemic Mitral Regurgitation ◽  
Mean Values ◽  
St Segment Elevation ◽  
Group Iii ◽  
Group I ◽  
Group Ii

Abstract Purpose The aim of this study was to assess the correlation between the size of acute functional ischemic mitral regurgitation (FIMR) and selected left ventricle echocardiography measurements in patients (pts) with first ST-segment elevation myocardial infarction (STEMI) treated with effective primary angioplasty (PCI). Methods We analyzed 1578 consecutive hospitalized pts with STEMI (M-914; 66,4 ± 10,2 years) treated with PCI. The echocardiographic examination was performed at up to 3 days after admission. We assessed the frequency and size of FIMR, left ventricular end diastolic diameter (LVEDd), ejection fraction (EF), wall motion score index (WMSI) and systolic sphericity index (Sls). Effective regurgitation orifice area (EROA) was used for quantitative FIMR assessment (mild: &lt;10 mm², moderate: ≥10 and &lt; 20 mm², severe: ≥ 20mm²). The study population was divided into four groups depending on the size of FIMR. Correlation coefficient was used to determine correlations between data sets. Results We observed mild FIMR in 550 pts (34,9%) - group I, moderate in 356 pts (22,5%) - group II, severe in 57 pts (3,6%) - group III, no FIMR in 615 pts (39%) – group IV. Mean values of selected echocardiographic parameters in each analyzed group are shown in table 1. The positive good correlations between SIs and size of FIMR were found (r = 0,68) as well as weak correlations between LVEDd, WMSI and FIMR (ro = 0,25, ro = 0,34, respectively). The negative weak correlation between EF and size of IMR was present (ro = - 0,34). Conclusions 1. FIMR is a common complication in pts with STEMI treated with PCI. 2. We found a statistically significant correlation between SIs and FIMR severity. Table 1 Group I Group II Group III Group IV p LVEDd (cm) 5,22 ± 0,64 5,42 ± 0,56 5,72 ± 0,64 4,98 ± 0,58 NS EF (%) 48 ± 6 42 ± 8 35 ± 8 51 ± 8 NS WMSI 1,34 ± 0,28 1,42 ± 0,24 1,68 ± 0,32 1,32 ± 0,22 NS SIs 0,22 ± 0,1 0,32 ± 0,1 0,68 ± 0,1 0,18 ± 0,1 0,01 NS - non-significant

Retroperfusion of the Ischemic Myocardium with Methysergide and Dipyridamole

1979 ◽  
Author(s):  
R.K. Kordenat
Keyword(s):  
Normal Saline ◽  
Balloon Catheter ◽  
Peripheral Resistance ◽  
Group Iv ◽  
Ischemic Myocardium ◽  
Mean Values ◽  
Group Iii ◽  
Catheter Technique ◽  
Group I ◽  
Mean Heart Rate

In four groups of 6 dogs each, an occluding thrombus was produced in the LAD coronary artery by placing a thrombogenic wire into the vessel, using a catheter technique (under x-ray control). One-haIf hour after occlusion was confirmed (angiographically) in Group I, methysergide (100 micrograms /kg, in 20 ml normal saline) was infused, retrograde, as a single bolus, into the ischemic myocardium, via the great cardiac vein, using a Swann-Gantz balloon catheter. In Group II, dipyridamole (2 mg/kg/ in 20 ml normal saline) was used and in Group III both drugs were combined. Group IV mean heart rate (HR), stroke volume (SV), cardiac output (CO) decreased from baseline (p<0.01, p<0.01 and p<0.001) at the third post-occlusion hour and total peripheral resistance (TPR increased (p<0.001). Few and Less significant changes and some improvement in these and other variables occurred in I and II over the observed period. There were no significant changes in any variable in III. CO, TPR and SV of Groups III and IV were significantly different (p<0.05 to p<0.01), when their mean values were compared at the first and third post-occlusion hours. It appeared that both drugs offer a protective hemodynamic effect during acute myocardial infarction and there may be a positive synergistic action between them.

scholarly journals Supplementation effect of medicinal plant leaves on growth in crossbred calves

2020 ◽  
Vol 34 (03) ◽  
Author(s):  
Ritu Raj ◽  
Anshu Rahal ◽  
Anil Kumar ◽  
S. K. Singh
Keyword(s):  
Body Weight ◽  
Dry Matter ◽  
Group Iv ◽  
Dry Matter Intake ◽  
Tinospora Cordifolia ◽  
Control Group ◽  
Mentha Arvensis ◽  
Group Iii ◽  
Group I ◽  
Group Ii

Effect of supplementing giloy (Tinospora cordifolia) and mint (Mentha arvensis) on feed intake and body weight was studied in twenty crossbred calves. While Group I was taken as control, Group II was supplemented with Tinospora cordifolia @ 4% of concentrate, group III with Mentha arvensis @ 4% of concentrate and group IV with both Tinospora cordifolia and Mentha arvensis @ 2% of concentrate each. Significantly higher(P 0.05) dry matter intake(Kg) and dry matter intake(g)/W 0.75Kg in group III was recorded compared to control while group II did not differ from group IV. Significantly higher body weight gain was noticed in group IV compared to other groups. Giloy and/or mint can be fed to improve growth in crossbred calves.

Sign in / Sign up

Export Citation Format

Share Document